慢性阻塞性肺疾病危险因素

[1] Genetic Polymorphism in Matrix Metalloproteinase-9 and Pulmonary Emphysema. Matsushita I,Hasegawa K,Nakata K,et al. Biochemical and Biophysical Research Communications . 2001

[2] Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Tamarina NA,McMillan WD,Shively VP et al. Journal of Surgery . 1997

[3] Regulation of monocyte MMP-9 production by TNF-alpha and a tumor-derived soluble factor(MMPSF). Laber TM,Balkwill FR. British Journal of Cancer . 1998

[4] The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Joos L,Hej Q,Shepherdson MB,et al. Human Molecular Genetics . 2002

[5] Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Ye S. Matrix Biology . 2000

[6] Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Matsushita I,Hasegawa K,Nakata K,et al. Biochemical and Biophysical Research Communications . 2002

[7] Adenoviral E1A modulates inflammatory mediator expression by lung epithelial cells exposed to PM10. Fujii T,Hogg JC,Keicho N,et al. American Journal of Physiology Lung Cellular and Molecular Physiology . 2003

[8] Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Higashimoto Y,Higashimoto Y,Elliott WM,et al. American Journal of Respiratory and Critical Care Medicine . 2002

[9] The genetics of chronic obstructive pulmonary disease. Lomas DA,Silverman EK. Respiratory Research . 2001

[10] Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Hirano K,Sakamoto T,Uchida Y,et al. European Respiratory Journal . 2001

[1] Genetic Polymorphism in Matrix Metalloproteinase-9 and Pulmonary Emphysema. Matsushita I,Hasegawa K,Nakata K,et al. Biochemical and Biophysical Research Communications . 2001

[2] Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Tamarina NA,McMillan WD,Shively VP et al. Journal of Surgery . 1997

[3] Regulation of monocyte MMP-9 production by TNF-alpha and a tumor-derived soluble factor(MMPSF). Laber TM,Balkwill FR. British Journal of Cancer . 1998

[4] The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Joos L,Hej Q,Shepherdson MB,et al. Human Molecular Genetics . 2002

[5] Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Ye S. Matrix Biology . 2000

[6] Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Matsushita I,Hasegawa K,Nakata K,et al. Biochemical and Biophysical Research Communications . 2002

[7] Adenoviral E1A modulates inflammatory mediator expression by lung epithelial cells exposed to PM10. Fujii T,Hogg JC,Keicho N,et al. American Journal of Physiology Lung Cellular and Molecular Physiology . 2003

[8] Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Higashimoto Y,Higashimoto Y,Elliott WM,et al. American Journal of Respiratory and Critical Care Medicine . 2002

[9] The genetics of chronic obstructive pulmonary disease. Lomas DA,Silverman EK. Respiratory Research . 2001

[10] Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Hirano K,Sakamoto T,Uchida Y,et al. European Respiratory Journal . 2001